vimarsana.com

Protocol Deviations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioVie Announces Efficacy Data from Phase 3 Trial of

BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer s Disease

Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker…

Are We Doing Enough to Save Lives in Oncology Clinical Trials?

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.